Larry Rodman
Technik-/Wissenschafts-/F&E-Leiter bei Lewis & Clark Pharmaceuticals, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Robert D. Thompson | M | - |
Lewis & Clark Pharmaceuticals, Inc.
 Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | 13 Jahre |
| Edward Williams | M | - |
Lewis & Clark Pharmaceuticals, Inc.
Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | - |
| Joel M. Linden | M | - |
Lewis & Clark Pharmaceuticals, Inc.
Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | - |
| Miette H. Michie | F | - |
Lewis & Clark Pharmaceuticals, Inc.
Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | - |
| C. Thomas Carter | M | - |
Lewis & Clark Pharmaceuticals, Inc.
Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | - |
| Jeffrey Totten | M | - |
Lewis & Clark Pharmaceuticals, Inc.
Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 6 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Larry Rodman
- Persönliches Netzwerk
